Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for f...

FDA Drug Recall #D-0238-2018 — Class II — January 9, 2018

Recall Summary

Recall Number D-0238-2018
Classification Class II — Moderate risk
Date Initiated January 9, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Marksans Pharma Inc.
Location Hauppauge, NY
Product Type Drugs
Quantity 21,584,100 tablets

Product Description

Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-121-29.

Reason for Recall

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Distribution Pattern

Distributed to repackaging firms in NY who then distributed Nationwide in the USA.

Lot / Code Information

Lot #: HK6001, HK6002, HK6003, HK6004, HK6005, HK6006, HK6007, HK6008, HK6009, HK6010, HK6011, HK6012, HK6013, HK6014, HK6015, Exp 09/18

Other Recalls from Marksans Pharma Inc.

Recall # Classification Product Date
D-0239-2018 Class II Ibuprofen Tablets, USP 600 mg, 6 x 2500 Tablets... Jan 9, 2018
D-0235-2018 Class II Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets... Jan 9, 2018
D-0240-2018 Class II Ibuprofen Tablets, USP 800 mg, 6 x 1900 Tablets... Jan 9, 2018
D-0237-2018 Class II Ibuprofen Tablets, USP 200 mg, 6 x 6500 Tablets... Jan 9, 2018
D-0236-2018 Class II Ibuprofen Tablets, USP 200 mg, 6 x 6500 Tablets... Jan 9, 2018

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.